ATHIRA PHARMA
Live / Applied — Second extension granted (statement of use) (as of 13 Aug 2025)
What this means for you
Not registered yet, but its 18 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97894381
- Mark type
- Stylized text
- Filed
- 18 Apr 2023
- Published for opposition
- 06 Aug 2024
- Attorney of record
- Kevin S. Costanza
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; pharmaceutical drug development services
Owner
- Athira Pharma, Inc., Seattle, WA, US
- Athira Pharma, Inc., Seattle, WA, US
Prosecution history
- 14 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Aug 2025 — SOU EXTENSION 2 GRANTED
- 13 Aug 2025 — SOU EXTENSION 2 FILED
- 13 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2025 — SOU EXTENSION 1 GRANTED
- 04 Mar 2025 — SOU EXTENSION 1 FILED
- 04 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2024 — PUBLISHED FOR OPPOSITION
- 17 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jun 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE